PATENT CLAIM ANALYSIS

Application Number: 15751547
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["562", "030000"]

Abstract:
Compounds, pharmaceutical compositions, methods and kits are described for treating or preventing neurodegenerative diseases such as Alzheimer's disease.

Claim (Index 17):
The compound of  claim 15 , wherein:\n R a1 , present, is selected from hydrogen, 4-amino cyclohexyl, 2-aminocyclohexyl, piperidin-4-yl, 2-(benzylamino)ethyl, 3-(dimethylamino)-2,2-dimethylpropyl, 5-amino-1-(hydroxycarbonyl)pentyl, 2-(1H-imidazol-4-yl)-1-hydroxycarbonylethyl, 1,2-bishydroxycarbonylethyl, 2-(1H-indo1-3-yl)-1-hydroxycarbonylethyl, 2-(4-hydroxyphenyl)-1-hydroxycarbonylethyl, 3-(methylthio)-1-hydroxycarbonylpropyl, 2-hydroxy-1-hydroxycarbonylpropyl, 2-hydroxy-1-hydroxycarbonylethyl, 3-methyl-1-hydroxycarbonylbutyl, 2-methyl-1-hydroxycarbonylpropyl, 2-phenyl-1-hydroxycarbonylethyl, 1-hydroxycarbonylethyl, hydroxycarbonylmethyl, and benzyl; and ring A, if present, is selected from 3-aminopyrrolidin-1-yl, piperazin-1-yl, 4-aminopiperidin-1-yl, and 2-aminopiperidin-1-yl .

Metadata:
- Claim Count in Document: 28.0
- Percentile: 88.0
- Lexical Diversity: 1.04762
- Patent Class: 562.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16320589', '14769421', '10307735', '15740462', '15312614']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7591449652264062
- 35 USC 102 Novelty (BERT): 0.5308922301704847
- Combined Prediction Score: 0.736319691720814
- Mean Citation Score: 338.91286
- Max Citation Score: 342.17654
- Similarity Product: 247.60352314029456

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test